Loris Bzk Swab
NDC Package 68356-126-04
Package Information
Loris Bzk (benzalkonium chloride) swabs is tear open pouch and use as part of your daily cleansing routine. This formulation utilizes a swab delivery system. Marketed by Lernapharm Loris Inc., this product is identified by NDC 68356-126 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Medicated Pad
- RxCUI: 1038558 - benzalkonium chloride 1.3 MG/ML Medicated Pad
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Topical Cloth
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Topical Swab
- RxCUI: 1038558 - benzalkonium chloride 0.13 GM per 100 GM Topical Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68356 - Lernapharm Loris Inc.
- 68356-126 - Loris Bzk
- 68356-126-04 - 2.6 g in 1 PACKET
- 68356-126 - Loris Bzk
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68356-126). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68356-126-04 identifies a specific commercial package of 2.6 g in 1 packet of Loris Bzk Antiseptic Wipes, a human over the counter drug labeled by Lernapharm Loris Inc.. This swab is formulated for topical use and contains benzalkonium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lernapharm Loris Inc. on November 21, 2012. The current certification is valid through December 31, 2027.
How is this Lernapharm Loris Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68356012604. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.